Major Depressive Disorder
Showing NaN - NaN of 113
MDD Trial in Worldwide (Placebo, Cariprazine)
Completed
- Major Depressive Disorder
- Placebo
- Cariprazine
-
Garden Grove, California
- +71 more
Mar 29, 2018
MDD Trial in Worldwide (LY2216684, Placebo, SSRI)
MDD Trial in Worldwide (LY2216684, Placebo, SSRI)
MDD Trial in Atlanta (Behavioral Activation, Fluoxetine)
Terminated
- Major Depressive Disorder
- Behavioral Activation
- Fluoxetine
-
Atlanta, GeorgiaEmory Executive Park
Nov 22, 2017
MDD Trial in United States (paroxetine CR)
Completed
- Major Depressive Disorder
- paroxetine CR
-
Birmingham, Alabama
- +70 more
Sep 8, 2017
MDD Trial in Worldwide (AZD6765 iv, Placebo)
Completed
- Major Depressive Disorder
- AZD6765 iv
- Placebo
-
Chino, California
- +43 more
Apr 10, 2017
MDD Trial in Worldwide (Placebo, RO4917523 0.5 mg, RO4917523 1.5 mg)
Completed
- Major Depressive Disorder
- Placebo
- +2 more
-
Little Rock, Arkansas
- +75 more
Nov 1, 2016
Phenotype Depression Study
Completed
- Major Depressive Disorder
-
Atlanta, GeorgiaEmory University Department of Psychiatry and Behavioral Science
Jun 20, 2016
MDD, Anxiety Trial in United States (Brexpiprazole)
Completed
- Major Depressive Disorder
- Anxiety
-
Tuscon, Arizona
- +20 more
Feb 26, 2016
MDD Trial in United States (GLYX-13 5 mg/kg, GLYX-13 10 mg/kg, Placebo)
Completed
- Major Depressive Disorder
- GLYX-13 5 mg/kg
- +2 more
-
Birmingham, Alabama
- +25 more
Feb 18, 2016
MDD Trial in United States (EB-1010 25mg BID, SSRI Active, EB-1010 50mg BID)
Completed
- Major Depressive Disorder
- EB-1010 25mg BID
- +3 more
-
Arcadia, California
- +42 more
Nov 5, 2015
NeuroStar TMS Therapy System: Utilization and Outcomes
Completed
- Major Depressive Disorder
-
Phoenix, Arizona
- +43 more
Nov 11, 2015
MDD Trial in United States (OPC-34712, Placebo, ADT)
MDD Trial in Atlanta (Escitalopram, Desipramine)
Completed
- Major Depressive Disorder
-
Atlanta, GeorgiaEmory University School of Medicine
Jul 15, 2015
MDD Trial in United States (tasimelteon, )
Completed
- Major Depressive Disorder
- tasimelteon
- placebo
-
Garden Grove, California
- +39 more
Jun 1, 2015
MDD Trial in Worldwide (Desvenlafaxine succinate sustained release 50 mg, Desvenlafaxine succinate sustained release 25 mg,
Completed
- Major Depressive Disorder
- Desvenlafaxine succinate sustained release 50 mg
- +2 more
-
Beverly Hills, California
- +88 more
Nov 6, 2014
MDD Trial in United States (Vilazodone, Placebo to citalopram, Placebo to vilazodone)
MDD Trial in United States (Levomilnacipran ER, Paroxetine, Sertraline, Citalopram or Fluoxetine., Placebo)
Completed
- Major Depressive Disorder
- Levomilnacipran ER
- +2 more
-
Birmingham, Alabama
- +19 more
Aug 5, 2014
MDD Trial in United States (Placebo, Escitalopram, JNJ-18038683)
Completed
- Major Depressive Disorder
- Placebo
- +2 more
-
Little Rock, Arkansas
- +25 more
Aug 1, 2014
MDD Trial in Australia, United States (Cervel Neurotech Deep Shaped-Field repetitive transcranial magnetic stimulator
Completed
- Major Depressive Disorder
- Cervel Neurotech Deep Shaped-Field repetitive transcranial magnetic stimulator (DSF-rTMS)
-
Atlanta, Georgia
- +3 more
May 15, 2014
MDD, Depression Trial in India, Puerto Rico, United States (TC-5214, Placebo)
Completed
- Major Depressive Disorder
- Depression
- TC-5214
- Placebo
-
Birmingham, Alabama
- +98 more
Mar 14, 2014
MDD Trial in United States (Dose-matched , Vilazodone)
Completed
- Major Depressive Disorder
- Dose-matched placebo
- Vilazodone
-
Beverly Hills, California
- +13 more
Feb 21, 2014